日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Immunogenicity and safety of biological E's 14-valent pneumococcal conjugate vaccine (PNEUBEVAX 14®) administered in a 2p + 1 schedule to healthy infants: a multicenter, randomized, active controlled, single-blind, phase III trial

一项多中心、随机、活性对照、单盲、III期临床试验，旨在评估生物制品公司E研发的14价肺炎球菌结合疫苗（PNEUBEVAX 14®）在健康婴儿中采用2p+1接种程序时的免疫原性和安全性。

期刊:Lancet Regional Health - Southeast Asia
影响因子:6.2
doi:10.1016/j.lansea.2026.100746
Thuluva, Subhash; Matur, Ramesh V; Gunneri, Subbareddy; Ningaiah, Siddalingaiah; Yerroju, Vijay; Mogulla, Rammohan Reddy; Dhar, Chirag; Thammireddy, Kamal; Paliwal, Piyush; Kawade, Anand; Nanjappa, Pradeep; Pramod, Jog; Narang, Manish; Chakravarthy, Bheemisetty S; Virupakashappa, Prashanth M
肺炎
免疫/内分泌
发表日期：2026
文献求助 收藏

Immunogenicity and Safety of Biological E's Monovalent rDNA Hepatitis B Vaccine (BEVAC(®)) in Neonates and Infants: A Multicentre, Randomized, Phase IV Non-Inferiority Trial

Biological E公司单价重组DNA乙型肝炎疫苗（BEVAC®）在新生儿和婴儿中的免疫原性和安全性：一项多中心、随机、IV期非劣效性试验

期刊:Viruses-Basel
影响因子:3.5
doi:10.3390/v18040472
Thuluva, Subhash; Gunneri, Subbareddy; Ningaiah, Siddalingaiah; Yerroju, Vijay; Mogulla, Rammohan Reddy; Dhar, Chirag; Thammireddy, Kamal; Esanakarra, Raju; Nanjappa, Pradeep; Mahantshetti, Niranjana S
免疫/内分泌
肝炎
发表日期：2026
文献求助 收藏

Behavioural and Social Drivers (BeSD) of COVID-19 vaccination for children: A cross-sectional study of parental vaccine confidence and intent in Mysore, India

印度迈索尔一项关于家长对儿童接种新冠疫苗的信心和意愿的横断面研究：行为和社会因素对儿童接种新冠疫苗的影响

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0316877
Muralidhar, Kiranmayee; Ngaybe, Maiya G Block; Pope, Benjamin; Nanjaiah, Shivamma; Coursey, Kate; Jaykrishna, Poornima; Ningaiah, Nagalambika; Edwards, Todd L; Edwards, Digna R Velez; Madhivanan, Purnima; Somaiya, Devanshi; Krupp, Karl
微生物学
新冠
发表日期：2026
文献求助 收藏

Corrigendum to 'Immunogenicity and safety of Biological E's CORBEVAX™ vaccine as a heterologous booster dose in adult volunteers previously vaccinated with two doses of either COVISHIELD™ or COVAXIN: A Prospective double-blind randomised phase III clinical study' [IJID Regions, volume 17 (2025) 100786]

对“Biological E 的 CORBEVAX™ 疫苗作为异源加强剂量在先前接种过两剂 COVISHIELD™ 或 COVAXIN 的成年志愿者中的免疫原性和安全性：一项前瞻性双盲随机 III 期临床研究”的更正 [IJID Regions，第 17 卷（2025 年）100786]

期刊:IJID Regions
影响因子:1.7
doi:10.1016/j.ijregi.2025.100831
Thuluva, Subhash; Paradkar, Vikram; Gunneri, SubbaReddy; Yerroju, Vijay; Mogulla, Rammohan Reddy; Thammireddy, Kamal; Ningaiah, Siddalingaiah; Dhar, Chirag; Binayke, Akshay; Zaheer, Aymaan; Awasthi, Amit; Narang, Shiva; Reddy, Naveen Chander; Pandey, Anil Kumar; Anjaneylu, Chitta Sitaram
免疫/内分泌
发表日期：2026
文献求助 收藏

Safety and immunogenicity of booster doses of an XBB.1.5 RBD subunit COVID-19 vaccine among individuals aged 5-80 years in India: a phase 3, single-blind, randomised controlled trial

在印度5-80岁人群中，XBB.1.5 RBD亚单位COVID-19疫苗加强剂量的安全性和免疫原性：一项3期单盲随机对照试验

期刊:Lancet Regional Health - Southeast Asia
影响因子:6.2
doi:10.1016/j.lansea.2025.100642
Thuluva, Subhash; Paradkar, Vikram; Gunneri, SubbaReddy; Mogulla, Rammohan Reddy; Yerroju, Vijay; Dhar, Chirag; Ningaiah, Siddalingaiah; Panchakshari, Mallikarjuna; Gillurkar, Chandrashekhar S; Narang, Manish; Kisan, Shivnitwar Sachin; Rao, A Venkateshwar
免疫/内分泌
发表日期：2025
文献求助 收藏

Beyond immunogenicity in XBB.1.5 subunit COVID-19 boosters focusing on durability, dosing, and target populations: authors reply

除了XBB.1.5亚单位COVID-19加强针的免疫原性之外，还应关注其持久性、剂量和目标人群：作者回复

期刊:Lancet Regional Health - Southeast Asia
影响因子:6.2
doi:10.1016/j.lansea.2025.100678
Thuluva, Subhash; Paradkar, Vikram; Gunneri, SubbaReddy; Mogulla, Rammohan Reddy; Yerroju, Vijay; Ningaiah, Siddalingaiah; Panchakshari, Mallikarjuna; Dhar, Chirag
免疫/内分泌
发表日期：2025
文献求助 收藏

Immunogenicity and safety of Biological E's CORBEVAX™ vaccine as a heterologous booster dose in adult volunteers previously vaccinated with two doses of either COVISHIELD™ or COVAXIN: A prospective double-blind randomized phase III clinical study

Biological E 公司的 CORBEVAX™ 疫苗作为异源加强剂在先前接种过两剂 COVISHIELD™ 或 COVAXIN 疫苗的成年志愿者中的免疫原性和安全性：一项前瞻性双盲随机 III 期临床研究

期刊:IJID Regions
影响因子:1.7
doi:10.1016/j.ijregi.2025.100786
Thuluva, Subhash; Paradkar, Vikram; Gunneri, SubbaReddy; Yerroju, Vijay; Mogulla, Rammohan Reddy; Thammireddy, Kamal; Ningaiah, Siddalingaiah; Dhar, Chirag; Binayke, Akshay; Zaheer, Aymaan; Awasthi, Amit; Narang, Shiva; Reddy, Naveen Chander; Pandey, Anil Kumar; Anjaneylu, Chitta Sitaram
免疫/内分泌
发表日期：2025
文献求助 收藏

Policy implications of integrating yoga for healthy Aging: A stakeholder analysis in India

将瑜伽融入健康老龄化政策的启示：印度利益相关者分析

期刊:
影响因子:
doi:10.1016/j.gerinurse.2025.103495
Krupp, Karl; Muralidhar, Kiranmayee; Behal, Anil; Jaykrishna, Poornima; Srinivas, Vijaya; Ningaiah, Nagalambika; Begum, Fazila; Edwards, Digna R Velez; Edwards, Todd L; Pereira, Pratibha; Madhivanan, Purnima; Shidhaye, Rahul
发表日期：2025
文献求助 收藏

Acceptability of HPV vaccination for cervical cancer prevention amongst emerging adult women in rural Mysore, India: a mixed-methods study

印度迈索尔农村地区新兴成年女性对HPV疫苗预防宫颈癌的接受度：一项混合方法研究

期刊:BMC Public Health
影响因子:3.6
doi:10.1186/s12889-024-19485-8
Coursey, Kate; Muralidhar, Kiranmayee; Srinivas, Vijaya; Jaykrishna, Poornima; Begum, Fazila; Ningaiah, Nagalambika; Lee, Sung-Jae; Madhivanan, Purnima
宫颈癌
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

A scenario of unhealthy life cycle: The role of circadian rhythms in health

不健康生命周期情景：昼夜节律在健康中的作用

期刊:Aging Medicine
影响因子:2.5
doi:10.1002/agm2.12301
Chandramouli, Manasa; Basavanna, Vrushabendra; Ningaiah, Srikantamurthy
发表日期：2024
文献求助 收藏